Congressional biotech commission warns of China deal flow
A bipartisan congressional panel that has steered much of the discourse on US biotech competitiveness is using its final weeks to highlight, and warn about, licensing deals with Chinese peers. The National Security Commission on ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.